Annovis Bio Inc (NYSE:ANVS) currently has a daily average trading volume of 375.68K but it saw 2714610 shares traded in last market. With a market cap of 63.14M USD, the company’s current market price of $3.24 came rising about 24.14 while comparing to the previous closing price of $2.61. In past 52 weeks, the stock remained buoying in the range of price level as high as $17.88 and as low as $1.11.
Maxim Group upgraded its recommendation for the stock as a “Buy” from “Hold” on October 25, 2024 while assigning a price target of $25. Canaccord Genuity issued its recommendations for the stock as it initiated the price target for the stock is $36.
Over the week, ANVS’s stock price is moving 33.33% up while it is 109.03% when we observe its performance for the past one month. Year-to-date it is -35.59% down and over the past year, the stock is showing a downside performance of -50.53%.
The company is expected to be releasing its next quarterly report in July, for which analysts forecasted an EPS of -0.39 while estimate for next year EPS is -1.09.
Currently, Annovis Bio Inc’s total number of outstanding shares is 19.49M with 14.31% of that held by the insiders while 16.03% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -120.81% and return on equity (ROE) at -280.78%. Stock’s beta reads 1.62. Stock has a price to book (P/B) ratio of 2.62. Its return on asset (ROA) is -168.22% on average.
